---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-140810"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T07:50:49.297320+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Whitehawk Therapeutics shareholders elect three Class II directors at annual meeting

## Summary
- Three Class II directors elected: Anupam Dalal (18.5M for, 5.0M withheld), Mohammad Hirmand (19.4M for, 4.2M withheld), David Lennon (19.4M for, 4.2M withheld).
- Board size decreased from 10 to 9 directorships upon opening of polls.
- Advisory vote on executive compensation passed: 18.9M for, 4.7M against, 14k abstentions.
- Ratification of BDO USA as auditor for FY2025 approved with 28.1M for, 524k against, 101k abstentions.

## SEC filing metadata
- accession: 0001193125-25-140810
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/0001193125-25-140810-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/d928055d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-140810
- JSON: https://secwatch.observer/filing/0001193125-25-140810.json
- Plain text: https://secwatch.observer/filing/0001193125-25-140810.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.